XEBIO holdings CO.,LTD.(8281) News

Notice Concerning Changes in Directors

Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

XEBIO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 41%, Oct-Dec Ordinary Profit Decreases by 55%

Notice Concerning Differences Between Forecast and Actual Results for the Second Quarter of FY2026 (Interim Period) and Revision of Full-Year Earnings

Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)

XEBIO, Net Income Forecast for the Fiscal Year Revised Downward to an Unexpected 76% Decrease

Notice Concerning the Determination of Allotment of Stock Acquisition Rights as Stock-Based Compensation-Type Stock Options to Directors

Notice Concerning the Allotment of Stock Acquisition Rights as Stock-Based Compensation-Type Stock Options to Directors

XEBIO, Apr-Jun (1Q) Net Income Decreases by 90%

Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)

Notice Concerning Determination of Terms for the Issuance of Stock Acquisition Rights as Stock Options

Notice Regarding Determination of Terms and Conditions for Issuance of Stock Acquisition Rights as Stock Options

Notice Concerning Completion of Transfer of “XEBIO Arena Sendai” to Sendai City and Finalization of Extraordinary Loss

Notice Regarding the Status and Completion of the Acquisition of Treasury Shares

[Summary]Consolidated Financial Results for the Fiscal Year Ended March 31,2025(Under Japanese GAAP)

XEBIO, 1% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2.5 yen

Notice Regarding the Status of Acquisition of Treasury Shares

Extraordinary Losses Related to Business Structural Reform in FY2024 Consolidated financial Results, and Revision of Earnings and Dividend Forecast

XEBIO, Last Fiscal Year Ordinary Profit Revised Upward by 21%, Dividend Revised Upward by 2.5 yen

Notice Concerning Changes in Directors